StockData
Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc. (RYTM) stock

RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)

Close on Nov 17, 2026Market cap $8.03BP/E –Yield –

Rhythm Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Rhythm Pharmaceuticals's total debt was $106.10M at Jun 30, 2026. For fiscal 2025 it was $108.18M, down 1.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$108.18M-1.5%
FY2024Dec 31, 2024$109.81M+3.5%
FY2023Dec 31, 2023$106.14M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$106.10M-3.4%
Q1 FY2026Mar 31, 2026$108.47M-1.0%
Q4 FY2025Dec 31, 2025$108.18M-1.5%
Q3 FY2025Sep 30, 2025$108.97M+2.7%
Q2 FY2025Jun 30, 2025$109.79M–
Q1 FY2025Mar 31, 2025$109.52M–
Q4 FY2024Dec 31, 2024$109.81M–
Q4 FY2023Dec 31, 2023$106.14M–

More Rhythm Pharmaceuticals figures

See a number that looks wrong?